AstraZeneca Breast Cancer Drug Extends Progression-Free Survival
WILMINGTON, DE — AstraZeneca reported updated Phase III trial results showing its investigational breast cancer therapy camizestrant extended the time patients lived without disease progression and delayed the need for …
AstraZeneca Breast Cancer Drug Extends Progression-Free Survival Read More